tirzepatide cause yeast infection Does Zepbound Infections? What to Know Mounjaro and Thrush: Symptoms, Risks

Californias Insurance Landscape for GLP-1s California Medicaid, known as Medi-Cal, has expanded GLP-1 coverage in recent years, but coverage for weight loss specifically (as opposed to type 2 diabetes) remains inconsistent

Watchpoints/Conclusion Research is early and inconsistent regarding the impact of diabetes and weight loss medications on bone density and an increased likelihood of repeat spinal surgeries, with implications for the safety of joint mobilizations, the prognosis of total joint replacements, and overall bone healing

Eli Lilly plans to submit orforglipron GLP-1 pill data to the FDA by the end of the year for consideration of the pill for weight loss management, and for Type 2 diabetes management in early 2026

Abstract Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, constitutes an effective and widely used treatment for type 2 diabetes and obesity

Why This Filing Matters Up to this point, Lillys strategyoutlined in the earlier filings I covered in The Mochi GLP-1 Case Explained and What Changed in Lillys v

Imaging cannot substitute a tissue diagnosis of cardiac masses